Lv79
3240 积分 2025-09-29 加入
A patent review of BRD4 inhibitors (2020–present)
4天前
已完结
Migraine
1个月前
已完结
Discovery of novel and selective SIK2 inhibitors by the application of AlphaFold structures and generative models
1个月前
已完结
Preclinical Characterization of ADCT-241, an Exatecan-Based Antibody–Drug Conjugate Against PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer
1个月前
已完结
Characterization and impact of peptide physicochemical properties on oral and subcutaneous delivery
1个月前
已完结
Clinical Activity of CC-90009, a Cereblon E3 Ligase Modulator and First-in-Class GSPT1 Degrader, As a Single Agent in Patients with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML): First Results from a Phase I Dose-Finding Study
2个月前
已完结
Design of Novel Exatecan-Amide Linker-Payloads for the Development of Stable, Low-Aggregating, and Highly Efficacious Antibody-Drug Conjugates
2个月前
已完结
New payloads drive next-gen antibody–drug conjugates
2个月前
已完结
Establishment of a new model of human multiple myeloma using NOD/SCID/γcnull (NOG) mice
2个月前
已完结
MAS-related G protein-coupled receptors X (MRGPRX): Orphan GPCRs with potential as targets for future drugs
2个月前
已完结